Misonix, Organogenesis join Russell Indexes

Alan Condon -   Print  |

Medical device companies Misonix and Organogenesis joined the Russell 2000 and 3000 Indexes.

Organogenesis was also added to the Russell Microcap Index, which Misonix is already included in.

Three things to know:

1. Russell indexes are commonly used by investors for index funds and as foundations for active investment plans. Roughly $9 trillion in assets are benchmarked against Russell's U.S. indexes.

2. FTSE Russell determines membership for its indexes by market-capitalization rankings and style attributes.

3. The Russell index changes became effective at market close on June 28.

"Our inclusion on the Russell indices marks yet another important milestone for Misonix and represents an opportunity to further increase our visibility and exposure among a broader and growing group of institutional investors," said Stavros Vizirgianakis, president and CEO of Misonix.

More articles on devices:
Saluda Medical raises $75M for spinal cord stimulation
Fusion Robotics to advance spinal robotic devices
Alexion drug receives FDA approval for rare autoimmune disease of spinal cord

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers